Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin in Hyperlipidemia
NCT02979704Phase 3Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Sep 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rosuvastatin and atorvastatin in hyperlipidemia, sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Malondialdehyde at 8 weeks. Status: unknown.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02979704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979704.